The Australasian Radiopharmaceutical Trials network is a collaborative network incorporating medical specialists, technologists, scientists and researchers from the field of Nuclear Medicine and Molecular Imaging with a shared interest in multicentre clinical trials that utilise radiopharmaceuticals for imaging or therapy.
The Australasian Radiopharmaceutical Trials network is a joint venture between the Australasian Association of Nuclear Medicine Specialists (AANMS) and the Australian and New Zealand Society of Nuclear Medicine (ANZSNM).

Mission Statement

To promote and facilitate innovative collaborative clinical research utilising radiopharmaceuticals for imaging or therapy.

Vision

  • to develop a network of radiopharmaceutical imaging and therapy sites in Australasia with validated capabilities;

  • to harmonise imaging protocols for research;

  • to facilitate linkages with other clinical trials networks, the pharma industry and funding agencies for multicentre clinical trials;

  • to support multicentre clinical trials with radiopharmaceutical for imaging or therapy, including facilitating data collection, analysis and data management;

  • to promote collaboration in clinical trials and outcome-based research with radiopharmaceuticals

Values

Quality – capitalising on our diverse expertise to deliver excellent outcomes

Innovation – implementing novel ideas to improve health care

Integrity – demonstrating a high level of professionalism in our endeavours

Leadership – being a strong role model for the conduct of high-quality, collaborative and innovative clinical trials, providing mentorship and training for the next generation of clinical researchers

Collaboration – developing new, and strengthening existing, relationships to create unique opportunities.

Mission Statement

To promote and facilitate innovative collaborative clinical research utilising radiopharmaceuticals for imaging or therapy.

Vision

  • to develop a network of radiopharmaceutical imaging and therapy sites in Australasia with validated capabilities;
  • to harmonise imaging protocols for research;
  • to facilitate linkages with other clinical trials networks, the pharma industry and funding agencies for multicentre clinical trials;
  • to support multicentre clinical trials with radiopharmaceuticals for imaging or therapy, including facilitating data collection, analysis and data management;
  • to promote collaboration in clinical trials and outcome-based research with radiopharmaceuticals.

Values

Quality – capitalising on our diverse expertise to deliver excellent outcomes
Innovation – implementing novel ideas to improve health care
Integrity – demonstrating a high level of professionalism in our endeavours
Leadership – being a strong role model for the conduct of high-quality, collaborative and innovative clinical trials, providing mentorship and training for the next generation of clinical researchers
Collaboration – developing new, and strengthening existing, relationships to create unique opportunities.